Voloridge Investment Management
ROIV icon

Voloridge Investment Management’s Roivant Sciences ROIV Stock Holding History

Voloridge Investment Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,672,720
Closed -$36.3M – 1237
2025
Q4 		$36.3M Sell
1,672,720
-608,403
-27% -$12M 0.13% 200
2025
Q3 		$34.5M Buy
+2,281,123
New +$28.2M 0.12% 214
2024
Q4 		– Sell
-1,253,226
Closed -$14.5M – 1344
2024
Q3 		$14.5M Buy
1,253,226
+843,570
+206% +$9.6M 0.05% 467
2024
Q2 		$4.33M Sell
409,656
-190,142
-32% -$2.08M 0.02% 788
2024
Q1 		$6.32M Buy
+599,798
New +$6.47M 0.02% 591
2023
Q4 		– Sell
-446,023
Closed -$5.21M – 1428
2023
Q3 		$5.21M Sell
446,023
-461,538
-51% -$5.22M 0.03% 642
2023
Q2 		$9.15M Sell
907,561
-90,020
-9% -$805K 0.04% 483
2023
Q1 		$7.36M Buy
997,581
+796,933
+397% +$6.56M 0.04% 551
2022
Q4 		$1.6M Buy
+200,648
New +$1.12M 0.01% 1027

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Voloridge Investment Management's ROIV Position: Q1 2026 in Review

Voloridge Investment Management sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 1,672,720 shares — an estimated $36.3M sold.

Voloridge Investment Management first reported a position in ROIV in Q4 2022 and held it in 9 quarters. The position peaked at $36.3M in Q4 2025. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Voloridge Investment Management reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 1,672,720 Roivant Sciences shares in Q1 2026, an estimated $36.3M.
  • Voloridge Investment Management first reported a position in Roivant Sciences in Q4 2022 and held it in 9 quarters.
  • Voloridge Investment Management's Roivant Sciences position peaked at $36.3M in Q4 2025.
  • 444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.